When sleep improves but AHI does not: comments on mepolizumab ± FESS in severe CRSwNP
Rhinology Journal · 01.05.2026 · 0-0
DOI: 10.4193/rhin26.159 ↗Kurz gefasst
Kommentar in der Zeitschrift Rhinology Journal, online erschienen am 01.05.2026. Verfasst von W-Z Hong. Beteiligte Einrichtung: Department of Otorhinolaryngology Head and Neck Surgery, Zhongshan Hospital of Traditional Chinese Medicine, Affiliated to Guangzhou University of Ch…. Hauptthemen laut MEDLINE: Rhinosinusitis, Antibodies, Monoclonal, Humanized, Sleep Apnea Syndromes.
Abstract (Originalsprache)
We read with great interest the randomized trial by Homoe et al. evaluating mepolizumab with or without functional endo-scopic sinus surgery (FESS) for severe uncontrolled CRSwNP (1), integrating patient-reported sleep outcomes (ESS, FOSQ-10, SNOT-22 sleep items) with WatchPAT-derived indices of sleep-disordered breathing (AHI/ODI). The study addresses a clinically frequent scenario in which patients report prominent fatigue and “poor sleep”, while OSA may coexist and require indepen-dent management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology Head and Neck Surgery, Zhongshan Hospital of Traditional Chinese Medicine, Affiliated to Guangzhou University of Chinese Medicine, Zhongshan, Guangdong, China.
Zitieren
APA
Hong, W. Z. (2026). When sleep improves but AHI does not: comments on mepolizumab ± FESS in severe CRSwNP. Rhinology Journal, 0(0), 0-0. https://doi.org/10.4193/rhin26.159
Vancouver
Hong WZ. When sleep improves but AHI does not: comments on mepolizumab ± FESS in severe CRSwNP. Rhinology Journal. 2026;0(0):0-0. doi:10.4193/rhin26.159
BibTeX
@article{Hong2026,
author = {Hong, W-Z},
title = {When sleep improves but AHI does not: comments on mepolizumab ± FESS in severe CRSwNP},
journal = {Rhinology Journal},
year = {2026},
volume = {0},
number = {0},
pages = {0--0},
doi = {10.4193/rhin26.159}
}
EUVIMED